Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease models

Linhui Julie Su(Whitehead Institute for Biomedical Research), Susan Lindquist(Howard Hughes Medical Institute), Tiago F. Outeiro(Universitätsmedizin Göttingen), Guy A. Caldwell(University of Alabama), Pavan K. Auluck(Harvard University), Shusei Hamamichi(University of Alabama), Kim A. Caldwell(University of Alabama), Daniel F. Tardiff(Whitehead Institute for Biomedical Research), Kathryn J. Hill(Garvan Institute of Medical Research), J. Michael McCaffery(Johns Hopkins University), Antony A. Cooper(Garvan Institute of Medical Research), Joshua A. Kritzer(Tufts University), Jean‐Christophe Rochet(Purdue University West Lafayette), Katherine E. Strathearn(Purdue University West Lafayette), Esti Yeger‐Lotem(Ben-Gurion University of the Negev), George W. Bell(Whitehead Institute for Biomedical Research), Fang Liu(Purdue University West Lafayette), Ernest Fraenkel(Broad Institute), Songsong Cao(University of Alabama)
Disease Models & Mechanisms
December 29, 2009
Cited by 176


Related Papers